USPTO serial 87625916
BOTANICA PERFECT GREENS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HETZEL, DANNEAN
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BOTANICA PERFECT GREENS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Olsen
Michael T. Olsen WINTHROP & WEINSTINE, P.A.225 SOUTH SIXTH STREETCAPELLA TOWER, SUITE 3500MINNEAPOLIS, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nutritional supplements and nutraceuticals, namely, vitamin supplements used to promote optimum energy, vitality and sound nutrition, amino acid supplements, mineral supplements and dietary herbal supplements, namely, a dietary herbal supplement to aid sports performance and endurance and work performance and endurance, a dietary herbal supplement to aid the immune system, a dietary herbal supplement to aid in weight management, a dietary herbal supplement to aid blood circulation, a dietary herbal supplement to aid metabolism; a dietary supplement medicated for antioxidant and anti-aging purposes; a dietary herbal supplement for promoting relaxation, reducing stress and relieving mental and physical fatigue in tablet, capsule, caplet, powder, liquid, ointment and tincture form; food replacement bars and food replacement drinks for medical purposes; dietary supplements for humans, namely, health bars; Herbal supplements for the treatment of arthritis; herbal supplements for the treatment of headaches; herbal supplements for the promotion of healthy liver function; herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; herbal supplements for use in dermatology, namely, dermatitis, eczema, psoriasis; herbal supplements for the treatment of infectious diseases, namely, urinary tract infections; herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries; herbal supplements for the treatment of dental and oral diseases; herbal supplements for the treatment of the respiratory system in tablet, capsule, caplet, powder, liquid, ointment and tincture form; herbal supplements for the treatment of cardiovascular diseases; herbal supplements, namely, bee pollen, beta carotene, bilberry, black cohosh, chamomile, evening primrose, echinacea, fennel, folic acid, vitamins; Herbal supplements, namely, echinacea extract in liquid form, liquid herbal extracts in liquid form for the normal cleansing of the circulatory system, lymphatic system, and liver, herbal extract in liquid form for normal menstrual functions, herbal extract in liquid form for promoting relaxation, restful sleep and reducing stress, frustration and nervousness, herbal extracts in pellet form for relieving gas and indigestion, headaches, mental and physical fatigue, menstrual disorder, back pain and spasms, and menopausal symptoms, nutritional supplements, namely, tablets containing vitamins, minerals and herbal concentrates, namely, concentrated preparations of withania somnifera, cinnamon, oregano, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian for nutritional supplemental purposes; preparations for treating colds, namely, tablets containing herbal extracts useful in treating colds, cough treatment preparations, namely, pellets of herbal extracts for relieving cough accompanied by laryngitis, pharyngitis, sinusitis, rhinitis, sneezing or post-nasal drip, dietary drink mixes and powder for use as a meal replacement, gargles, herbal teas for medicinal purposes; Homeopathic remedies for the treatment of colds and flu; homeopathic remedies for the treatment of headaches; homeopathic remedies for the treatment of morning sickness; homeopathic remedies for the treatment of stomach ulcers; homeopathic remedies for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; homeopathic remedies for treatment of skin conditions, namely, dermatitis, eczema, psoriasis; homeopathic remedies for the treatment of dental and oral diseases; dietary supplements for humans, namely, sodium phosphate for treating constipation; homeopathic remedies, namely, medicinal herbal preparations containing wild hops for treating sleep issues; homeopathic remedies, namely, sea kelp for treating hypo-thyroid function; homeopathic remedies, namely, witch hazel; homeopathic remedies, namely, St. John's wort in tablet, capsule, caplet, powder, liquid, ointment and tincture form; Medicinal tonics, made of medler (Chinese traditional medicine), medicines for human purposes, namely, antibacterials, antidiarrheals, antiviral; medicinal drinks, drug in liquid form, namely, antibacterials, antidiarrheals, antivirals; drugs for medical purposes, namely, antibacterials, antidiarrheals, antivirals; medlar (Chinese traditional medicine); capsules for medicines sold empty for antibacterials, antidiarrheals, antivirals; medicinal liquor, made of medlar (Chinese traditional medicine); Dietary and nutritional supplements containing minerals, amino acids, essential fatty acids and probiotics; Amino acids for nutritional purposes; Dietary supplement beverage for aiding digestion; Herbal supplements, namely, withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, oregano, passion flower, rhodiola, St. John's Wort, turmeric, and valerian ; Herbs for medicinal purposes, namely, withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, oregano, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian ; Homeopathic supplements, namely, nutritional supplements containing fish oil and herbal preparations, namely, withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian, goji berries; Liquid nutritional supplements, namely, nutritional supplements in liquid form containing withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, valerian, wormwood, and mushrooms; Medicinal alcohol; Medicinal herb extracts for medical purposes, namely, extracts containing withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian; Medicinal herbal extracts for medical purposes, namely, withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian; Mineral supplements; Nutraceuticals for use as a dietary supplement, namely, preparations containing withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplements, namely, preparations containing withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, valerian, iron, licorice root, gingko, lemon, red clover, cilantro, feverfew, dandelion root, chastetree, california poppy; chamomile, calendula, black cohosh, black walnut, blessed thistle, bladderwrack, mushrooms, ginger, mullein, nettle leaf, skullcap, and siberian ginseng; Nutritional supplements in the form of nutritional supplements containing essential fatty acids, namely, omega-3 fatty acids and nutritional supplements containing herbal extracts, namely, withania somnifera, cinnamon, astragalus, fenugreek, echinacea, goldenseal, green tea, hawthorn, basil, kava root, maca root, milk thistle, olive leaf, passion flower, rhodiola, St. John's Wort, turmeric, and valerian; Vitamin and mineral supplements; Vitamins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tallgrass Natural Health Ltd.
- Other trademarks owned by Tallgrass Natural Health Ltd.
- Other trademarks in Class 005
- Similar marks named BOTANICA PERFECT GREENS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 6, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 6, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 14, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2023 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 8, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 12, 2023 | IUAF | USE AMENDMENT FILED | — |
| Jan 12, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 18, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 18, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 18, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 18, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 14, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 12, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 12, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 12, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 12, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 14, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 12, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 12, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 12, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 12, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 26, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 26, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 26, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 25, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 11, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 11, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 11, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 6, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 6, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 6, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 5, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 26, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 26, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 26, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 25, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 2, 2017 | NWAP | NEW APPLICATION ENTERED | — |